|
Novel |
ACE |
angiotensin I converting enzyme |
- Metabolism of Angiotensinogen to Angiotensins
|
- Ramipril
- Fosinopril
- Trandolapril
- Benazepril
- Enalapril
- Candoxatril
- Moexipril
- Lisinopril
- Perindopril
- Quinapril
- Omapatrilat
- Rescinnamine
- Captopril
- Cilazapril
- Spirapril
- Epicaptopril
- N-acetyl-alpha-D-glucosamine
- Temocapril
- Enalaprilat
- Zofenopril
- Cilazaprilat
|
- Allograft rejection
- Renal tubular dysgenesis
|
|
Novel |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
|
- Flavin adenine dinucleotide
- MCC
|
- Combined oxidative phosphorylation deficiency (COXPD)
|
|
Novel |
ATP5PD |
ATP synthase peripheral stalk subunit d |
- Formation of ATP by chemiosmotic coupling
- Cristae formation
- Mitochondrial protein degradation
|
|
|
|
Novel |
CBX1 |
chromobox 1 |
|
|
|
|
Novel |
PCTP |
phosphatidylcholine transfer protein |
- Synthesis of PC
- Mitochondrial Fatty Acid Beta-Oxidation
|
- Palmitoyl-Linoleoyl Phosphatidylcholine
- L-Dilinoleoyllecithin
|
|
|
Novel |
SPDYA |
speedy/RINGO cell cycle regulator family member A |
|
|
|
|
Novel |
TANC2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
|
|
|
|
Novel |
TK1 |
thymidine kinase 1 |
- G1/S-Specific Transcription
- Pyrimidine salvage
|
- Dithioerythritol
- Thymidine 5'-triphosphate
|
|
|
Novel |
TLK2 |
tousled like kinase 2 |
|
|
|
|
Novel |
YWHAB |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta |
- Activation of BAD and translocation to mitochondria
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- MTOR signalling
- mTORC1-mediated signalling
- Frs2-mediated activation
- Frs2-mediated activation
- ARMS-mediated activation
- Signaling by Hippo
- Rap1 signalling
- Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
- Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
- RHO GTPases activate PKNs
- TP53 Regulates Metabolic Genes
- RAF activation
- MAP2K and MAPK activation
- Negative regulation of MAPK pathway
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- Regulation of localization of FOXO transcription factors
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- SHOC2 M1731 mutant abolishes MRAS complex function
- Gain-of-function MRAS complexes activate RAF signaling
- SARS-CoV-1 targets host intracellular signalling and regulatory pathways
- SARS-CoV-2 targets host intracellular signalling and regulatory pathways
- Transcriptional and post-translational regulation of MITF-M expression and activity
|
- Copper
- Phenethyl Isothiocyanate
|
|
|
|
APP |
amyloid beta precursor protein |
- Platelet degranulation
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosome Vesicle Biogenesis
- Formyl peptide receptors bind formyl peptides and many other ligands
- TAK1-dependent IKK and NF-kappa-B activation
- The NLRP3 inflammasome
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Post-translational protein phosphorylation
- TRAF6 mediated NF-kB activation
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Purinergic signaling in leishmaniasis infection
- Amyloid fiber formation
|
- Deferoxamine
- Aluminium
- Zinc
- L-methionine (R)-S-oxide
- Resveratrol
- Tromethamine
- Phenserine
- Tetrathiomolybdate
- CAD106
- Mito-4509
- Edonerpic
- Dimercaprol
- Copper
- Florbetaben (18F)
- Florbetapir (18F)
- Flutemetamol (18F)
- Gantenerumab
- Aducanumab
- Zinc acetate
- Aluminium phosphate
- Aluminum acetate
- Zinc chloride
- Zinc sulfate, unspecified form
- Lecanemab
|
|
|
|
ATP13A2 |
ATPase cation transporting 13A2 |
- Ion transport by P-type ATPases
|
|
|
|
|
BMPR1B |
bone morphogenetic protein receptor type 1B |
|
|
- Acromesomelic dysplasia with genital anomalies
- Brachydactyly, including: type A; type B; type D; type E
|
|
|
DYRK1B |
dual specificity tyrosine phosphorylation regulated kinase 1B |
|
|
|
|
|
LIG1 |
DNA ligase 1 |
- POLB-Dependent Long Patch Base Excision Repair
- Early Phase of HIV Life Cycle
- Processive synthesis on the C-strand of the telomere
- Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
- Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
- PCNA-Dependent Long Patch Base Excision Repair
- Gap-filling DNA repair synthesis and ligation in GG-NER
- Gap-filling DNA repair synthesis and ligation in TC-NER
- Processive synthesis on the lagging strand
- Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence
|
|
- DNA repair defects, including the following six diseases: Ataxia telangiectasia (AT); Ataxia-talangiectasia-like syndrome; Nijmegen syndrome; DNA ligase I deficiency; DNA ligase IV deficiency; Bloom's syndrome
|
|
|
PWP2 |
PWP2 small subunit processome component |
- rRNA modification in the nucleus and cytosol
- Major pathway of rRNA processing in the nucleolus and cytosol
|
|
|
|
|
YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma |
- Activation of BAD and translocation to mitochondria
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- RHO GTPases activate PKNs
- TP53 Regulates Metabolic Genes
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- AURKA Activation by TPX2
- Regulation of localization of FOXO transcription factors
- SARS-CoV-1 targets host intracellular signalling and regulatory pathways
- SARS-CoV-2 targets host intracellular signalling and regulatory pathways
- Transcriptional and post-translational regulation of MITF-M expression and activity
- SPOP-mediated proteasomal degradation of PD-L1(CD274)
|
|
|